Cargando…

Limitations for health research with restricted data collection from UK primary care

PURPOSE: UK primary care provides a rich data source for research. The impact of proposed data collection restrictions is unknown. This study aimed to assess the impact of restricting the scope of electronic health record (EHR) data collection on the ability to conduct research. The study estimated...

Descripción completa

Detalles Bibliográficos
Autores principales: Strongman, Helen, Williams, Rachael, Meeraus, Wilhelmine, Murray‐Thomas, Tarita, Campbell, Jennifer, Carty, Lucy, Dedman, Daniel, Gallagher, Arlene M., Oyinlola, Jessie, Kousoulis, Antonis, Valentine, Janet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6618795/
https://www.ncbi.nlm.nih.gov/pubmed/30993808
http://dx.doi.org/10.1002/pds.4765
_version_ 1783433901442596864
author Strongman, Helen
Williams, Rachael
Meeraus, Wilhelmine
Murray‐Thomas, Tarita
Campbell, Jennifer
Carty, Lucy
Dedman, Daniel
Gallagher, Arlene M.
Oyinlola, Jessie
Kousoulis, Antonis
Valentine, Janet
author_facet Strongman, Helen
Williams, Rachael
Meeraus, Wilhelmine
Murray‐Thomas, Tarita
Campbell, Jennifer
Carty, Lucy
Dedman, Daniel
Gallagher, Arlene M.
Oyinlola, Jessie
Kousoulis, Antonis
Valentine, Janet
author_sort Strongman, Helen
collection PubMed
description PURPOSE: UK primary care provides a rich data source for research. The impact of proposed data collection restrictions is unknown. This study aimed to assess the impact of restricting the scope of electronic health record (EHR) data collection on the ability to conduct research. The study estimated the consequences of restricted data collection on published Clinical Practice Research Datalink studies from high impact journals or referenced in clinical guidelines. METHODS: A structured form was used to systematically analyse the extent to which individual studies would have been possible using a database with data collection restrictions in place: (1) retrospective collection of specified diseases only; (2) retrospective collection restricted to a 6‐ or 12‐year period; (3) prospective and retrospective collection restricted to non‐sensitive data. Outcomes were categorised as unfeasible (not reproducible without major bias); compromised (feasible with design modification); or unaffected. RESULTS: Overall, 91% studies were compromised with all restrictions in place; 56% studies were unfeasible even with design modification. With restrictions on diseases alone, 74% studies were compromised; 51% were unfeasible. Restricting collection to 6/12 years had a major impact, with 67 and 22% of studies compromised, respectively. Restricting collection of sensitive data had a lesser but marked impact with 10% studies compromised. CONCLUSION: EHR data collection restrictions can profoundly reduce the capacity for public health research that underpins evidence‐based medicine and clinical guidance. National initiatives seeking to collect EHRs should consider the implications of restricting data collection on the ability to address vital public health questions.
format Online
Article
Text
id pubmed-6618795
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-66187952019-07-22 Limitations for health research with restricted data collection from UK primary care Strongman, Helen Williams, Rachael Meeraus, Wilhelmine Murray‐Thomas, Tarita Campbell, Jennifer Carty, Lucy Dedman, Daniel Gallagher, Arlene M. Oyinlola, Jessie Kousoulis, Antonis Valentine, Janet Pharmacoepidemiol Drug Saf Original Reports PURPOSE: UK primary care provides a rich data source for research. The impact of proposed data collection restrictions is unknown. This study aimed to assess the impact of restricting the scope of electronic health record (EHR) data collection on the ability to conduct research. The study estimated the consequences of restricted data collection on published Clinical Practice Research Datalink studies from high impact journals or referenced in clinical guidelines. METHODS: A structured form was used to systematically analyse the extent to which individual studies would have been possible using a database with data collection restrictions in place: (1) retrospective collection of specified diseases only; (2) retrospective collection restricted to a 6‐ or 12‐year period; (3) prospective and retrospective collection restricted to non‐sensitive data. Outcomes were categorised as unfeasible (not reproducible without major bias); compromised (feasible with design modification); or unaffected. RESULTS: Overall, 91% studies were compromised with all restrictions in place; 56% studies were unfeasible even with design modification. With restrictions on diseases alone, 74% studies were compromised; 51% were unfeasible. Restricting collection to 6/12 years had a major impact, with 67 and 22% of studies compromised, respectively. Restricting collection of sensitive data had a lesser but marked impact with 10% studies compromised. CONCLUSION: EHR data collection restrictions can profoundly reduce the capacity for public health research that underpins evidence‐based medicine and clinical guidance. National initiatives seeking to collect EHRs should consider the implications of restricting data collection on the ability to address vital public health questions. John Wiley and Sons Inc. 2019-04-16 2019-06 /pmc/articles/PMC6618795/ /pubmed/30993808 http://dx.doi.org/10.1002/pds.4765 Text en © 2019 Crown Copyright. Pharmacoepidemiology & Drug Safety Published by John Wiley & Sons, Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Reports
Strongman, Helen
Williams, Rachael
Meeraus, Wilhelmine
Murray‐Thomas, Tarita
Campbell, Jennifer
Carty, Lucy
Dedman, Daniel
Gallagher, Arlene M.
Oyinlola, Jessie
Kousoulis, Antonis
Valentine, Janet
Limitations for health research with restricted data collection from UK primary care
title Limitations for health research with restricted data collection from UK primary care
title_full Limitations for health research with restricted data collection from UK primary care
title_fullStr Limitations for health research with restricted data collection from UK primary care
title_full_unstemmed Limitations for health research with restricted data collection from UK primary care
title_short Limitations for health research with restricted data collection from UK primary care
title_sort limitations for health research with restricted data collection from uk primary care
topic Original Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6618795/
https://www.ncbi.nlm.nih.gov/pubmed/30993808
http://dx.doi.org/10.1002/pds.4765
work_keys_str_mv AT strongmanhelen limitationsforhealthresearchwithrestricteddatacollectionfromukprimarycare
AT williamsrachael limitationsforhealthresearchwithrestricteddatacollectionfromukprimarycare
AT meerauswilhelmine limitationsforhealthresearchwithrestricteddatacollectionfromukprimarycare
AT murraythomastarita limitationsforhealthresearchwithrestricteddatacollectionfromukprimarycare
AT campbelljennifer limitationsforhealthresearchwithrestricteddatacollectionfromukprimarycare
AT cartylucy limitationsforhealthresearchwithrestricteddatacollectionfromukprimarycare
AT dedmandaniel limitationsforhealthresearchwithrestricteddatacollectionfromukprimarycare
AT gallagherarlenem limitationsforhealthresearchwithrestricteddatacollectionfromukprimarycare
AT oyinlolajessie limitationsforhealthresearchwithrestricteddatacollectionfromukprimarycare
AT kousoulisantonis limitationsforhealthresearchwithrestricteddatacollectionfromukprimarycare
AT valentinejanet limitationsforhealthresearchwithrestricteddatacollectionfromukprimarycare